Sfe Investment Counsel Astrazeneca PLC Transaction History
Sfe Investment Counsel
- $543 Million
- Q2 2025
A detailed history of Sfe Investment Counsel transactions in Astrazeneca PLC stock. As of the latest transaction made, Sfe Investment Counsel holds 6,085 shares of AZN stock, worth $501,404. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,085
Previous 7,121
14.55%
Holding current value
$501,404
Previous $523,000
18.74%
% of portfolio
0.08%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,449Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...